State of Michigan Retirement System increased its stake in Biogen by 59.9% during the fourth quarter. State of Michigan Retirement System now owns 63,503 shares of the biotechnology company’s ...

But I think we have great teams within Biogen and we are able to really dissect ... could potentially alleviate some of the stress in the health care system. But importantly, there is going ...

Image caption: Medtech and pharmaceutical industry executive Lisa Shafer, Ph.D., will keynote the 2025 Bioelectronic Medicine ...

Biogen Canada Inc. is pleased to announce that Health Canada has approved SKYCLARYStm (omaveloxolone) for the treatment of Friedreich's ataxia (FA) in patients 16 years of age and older.2 This ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

The University of Copenhagen is excited to announce Maxwell Biosciences as Tier 1 Sponsor of the 12th Aging Research & Drug ...

For Biogen, dapirolizumab pegol is part of a push into the inflammatory and immunological diseases area and diversification away from its traditional focus on central nervous system diseases.

NeuroSense's Groundbreaking ALS Combination Therapy PrimeC Advances Towards commercialization in Canada; Potential for revenue in Canada alone of $100-150 million dollars. PrimeC Has Previously ...

With ongoing breakthroughs in gene and RNA therapies, coupled with regulatory encouragement and AI-based innovation, the market for treating rare neurological diseases is on the cusp of a ...

Existing research indicates that the accuracy of a Parkinson’s disease diagnosis hovers between 55% and 78% in the first five years of assessment. That’s partly because Parkinson’s sibling movement ...

Biogen and Sangamo have begun a collaboration ... to abnormal aggregates of alpha-synuclein protein in the nervous system and brain, including Parkinson’s. The deal also covers a third ...